Pricing
Follow
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Unverified
6 people · 0 jobs
5 people · 0 jobs
3 people · 0 jobs
2 people · 0 jobs
1 person · 0 jobs
Eindhoven
HQ
4 people · 0 jobs
Othram
3 followers
Capricor Therapeutics
2 followers
Edgewise Therapeutics
Avalyn Pharma
Gridware
Entos
1 follower
DNAnexus
9 followers
Mariana Oncology
Monod Bio
Utilidata
MontyCloud
Thermo Fisher Scientific
286 followers